T
Tero Aittokallio
H-index:73
Citation Count:1.9万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
An integrated spatially defined roadmap of normal and cancer-associated colon fibroblasts
正常和癌症相关结肠成纤维细胞的整合空间定义路线图
A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax
一种功能性预后模型预测接受伊布替尼联合维奈克拉治疗复发性慢性淋巴细胞白血病患者无进展生存期
HemaSphere
IF14.6
A host-centric morphological profiling approach to identify repurposed antiviral drugs
以宿主为中心的形态学分析新方法用于识别新用途的抗病毒药物
iScience
IF4.1
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib
具有激活STAT5B突变的肝脾 γ δ T细胞淋巴瘤的临床前模型对JAK抑制剂upadacitinib敏感
HemaSphere
IF14.6
Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data
通过混合集成特征选择和多组学数据发现胰腺癌预后生物标志物
BioData Mining
IF6.1
Path-based quantification of activation and repression in Boolean models using BooLEVARD
基于BooLEVARD的布尔模型中激活和抑制的路径量化
Spatial artifact detection improves the reproducibility of drug screening experiments
空间伪影检测提高了药物筛选实验的可重复性
iScience
IF4.1
Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas
基于分子信息的成熟T细胞白血病和淋巴瘤的治疗策略发现
Blood Advances
IF7.1
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient
蛋白酶体抑制在B细胞恶性模型和索引患者中克服靶向治疗耐药性
Cell Death & Disease
IF9.6
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma
双重特异性STAT3/5降解剂有效阻断急性髓系白血病和自然杀伤/T细胞淋巴瘤
HEMASPHERE
IF14.6
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones
单细胞转录组鉴定针对癌症克隆的选择性共抑制的患者定制疗法
NATURE COMMUNICATIONS
IF15.7
RepurposeDrugs: an interactive web-portal and predictive platform for repurposing mono- and combination therapies
重新利用药物: 一个交互式门户网站和预测平台,用于重新利用单一疗法和联合疗法

